Enhancing Plasma Nfl Prognostic Value and Improving Trial Efficiency through Digital Twins in ALS

Incorporating digital twins enhances the power of ALS clinical trials, strengthening confidence in decision-making and facilitating the advancement of clinical programs into later stages of development while aligning with regulatory guidance. Our method optimally leverages plasma NfL, extending its value for improving trial efficiency.